De Lombaert et al. Dual Inhibition of Angiotensin-Converting Enzyme and Neutral Endopeptidase By Tricyclic Benzazepinone Thiols Bioorg. Med. Chem. Lett. 6, 2875-2880 (1996). |
Flynn et al. an Acyl-Iminum Ion Cyclization Route to a Novel Conformationally Restricted Dipeptide Mimic: Applications to Angiotensin-Converting Enzyme Inhibition J. Amer Chem. Soc. 109, 7914-7915 (1987). |
Flynn et al. An Acyl-Iminium Ion Cyclization Route to Novel. Conformationally Restricted Dipeptide Mimics: Application to Angiotensin—Converting Enzyme Inhibition Peptide Chemistry 631-636 (1987); T. Shiba and S. Sakakibara (ed.), Protein Research Foundation, Osaka (1988). |
Flynn et al. The Conversion of a Diazolactam to an α-Methylenelactam: An Entrance to New Conformationally Restricted Inhibitors of Angiotensin—Converting Enzyme Tetrahedron Letters, 31, 815-818 (1990). |
Attwood et al. The Design and Synthesis of the Angiotensin Converting Enzyme Inhibitor Cilazapril and Related Bicyclic Compounds J. Chem. Soc. Perkin Trans. I, 1011-1019 (1986). |
I. L. Natoff and S. Redshaw Angiotensin—Converting Enzyme Inhibitors—Cilazapril and Other Bicyclic Hexahydropyridazines Drugs of the Future, 12, 475-483 (1987). |
Powell et al. Suppression of the Vascular Response to Injury: The Role of Angiotensin—Converting Enzyme Inhibitors Journal of American College of Cardiology, 17, 137B-142B (1991). |
Davis Jr. et al. Atrial Natriuretic Factor and the Neutral Endopeptidase Inhibitor SCH42495 Prevent Myointimal Proliferation after Vascular Injury Circulation, Supplement I, 86, I-220 (abstract 0873) (Oct. 1992). |
Ocain et al. New Modified Heterocyclic Phenylalanine Derivatives. Incorporation into Potent Inhibitors of Human Renin J. Med. Chem., 35, 823-832 (1992). |
Flynn et al. An Acyliminium Ion Route to cis and trans “Anti” Phe-Gly Dipeptide Mimetics Bioorg. Med. Chem. Lett., 1, 309-312 (1991). |
Fournie-Zaluski et al. “Mixed Inhibitor-Prodrug” as a New Approach Toward Systemically Active Inhibitors of Enkephalin—Degrading Enzymes J. Med. Chem., 35, 2473-2481 (1992). |
Fournie-Zaluskie et al. Potent and Systemically Active Aminopeptidase N Inhibitors Designed from Active-Site Investigation J. Med. Chem., 35. 1259-1266 (1992). |
French et al. Characterization of a Dual Inhibitor of Angiotensin I-Converting Enzyme and Neutral Endopeptidase J. Pharmacol. Exptl. Therap., 268, 180-186 (1994). |
Parsons et al. Benzolactams: A New Class of Converting Enzyme Inhibitors Biochem. Biophys. Res. Commun., 117, 108-113 (1983). |
Burkholder et al. The Synthesis of 6-Amino-5-oxo-7-phenyl-1,4-oxazepines as Conformationally Constrained Gauche (-) Dipeptide Mimetics Bioorg. Med. Chem. Lett., 3, 231-234 (1993). |
Flynn et al. Application of a Conformationally Restricted Phe-Leu Dipeptide Mimetic to the Design of a Combined Inhibitor of Angiotensin I-Converting Enzyme and Neutral Endopeptidase 24.11 J. Med. Chem., 36, 2420-2423 (1993). |
Robl et al. Stereoselective Routes Towards the Generation of Novel Bicyclic Azepinones as Conformationally Restricted Dipeptide beta-Turn Mimetics 34th National Organic Symposiuim, Poster 133 abstract, Jun. 11-15, 1995. |
Oinuma et al. The Creation of Isoleucine Derivatives as Orally-Potent, Dual Inhibitors of NEP and ACE: Design and Pharmacology 209th American Chemical Society Meeting, Anaheim CA, Apr. 2-7, 1995, Poster MEDI 161. |
Simpkins et al. Dual ACE/NEP Inhibitors: Synthesis and Activity of Mercaptoacyl Dipeptides Containing Conformationally Restricted Dipeptide Surrogates 210th American Chemical Society Meeting, Chicago, IL, Aug. 20-24, 1995, Poster MEDI 064. |
Brown et al. Improved Procedure for the Asymmetric Reduction of Prochiral Ketones by β-(3-Pinanyl)-9-borabicyclo[3.3.1]nonane J. Org. Chem., 47, 1606-1608 (1982). |
Midland et al. Asymmetric Reduction of Prochiral Ketones with β-(3-Pinanyl)-9-borabicyclo[3.3.1]nonane in Efficiencies Approaching 100%. Simultaneous Rate Enhancement and Side Reaction Suppression via the Use of Elevated Pressures. J. Org. Chem., 49, 1316-1317 (1984). |
Brown et al. Remarkable Optical Induction in the Reduction of α-Keto Esters with β-(3-Pinanyl)-9-borabicyclo[3.3.1]nonane. Synthesis of α-Hydroxy Esters of 100% Optical Purity J. Am. Chem. Soc., 106, 1531-1533 (1984). |